2.10.2 Fibrinolytic drugs
Alteplase
Alteplase 10mg powder and solvent for solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary embolism |
| Cardiovascular system | Ischaemic stroke |
Alteplase 20mg powder and solvent for solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary embolism |
| Cardiovascular system | Ischaemic stroke |
Alteplase 2mg powder for solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Cardiovascular conditions in specialist settings |
Alteplase 50mg powder and solvent for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary embolism |
| Cardiovascular system | Ischaemic stroke |
Tenecteplase
Tenecteplase 10,000unit powder and solvent for solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Acute ST-elevation myocardial infarction |
Tenecteplase 5,000unit powder for solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Ischaemic stroke |
Urokinase
Urokinase 25,000unit powder for solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Cardiovascular conditions in specialist settings |